On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Spark Therapeutics (United States)

InstitutionResearch output, impact & collaborations

Spark Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Spark Therapeutics (United States)?

ScholarIQrecord summary

Spark Therapeutics (United States) is a research organisation in Philadelphia, US. OpenAlex records 738 works and 59,209 citations for it. 375 researchers list it as their most recent affiliation.

How many works does Spark Therapeutics (United States) have?

ScholarIQindexed works

Spark Therapeutics (United States) has 738 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Spark Therapeutics (United States) →

How many citations does Spark Therapeutics (United States) have?

ScholarIQcitation count

Spark Therapeutics (United States) has 59,209 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Spark Therapeutics (United States) →

How many researchers are at Spark Therapeutics (United States)?

ScholarIQresearcher count

Spark Therapeutics (United States) has 375 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Spark Therapeutics (United States)?

ScholarIQavg h-index

Spark Therapeutics (United States) has an average h-index of 40 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Spark Therapeutics (United States)?

ScholarIQror

The ROR for Spark Therapeutics (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Spark Therapeutics (United States)?

ScholarIQopenalex

The OpenAlex for Spark Therapeutics (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Spark Therapeutics (United States)?

ScholarIQtop researchers by citations

Pichai Raman · Neuroblastoma Research and Treatments

220 works20,091 citations

What are the most-cited papers on Spark Therapeutics (United States)?

ScholarIQmost cited works

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Jordi Barretina, Giordano Caponigro, Nicolas Stransky, K. Venkatesan, Adam A. Margolin, Sung Joon Kim, Christopher J. Wilson, Joseph Lehár, Gregory V. Kryukov, Dmitriy Sonkin, Anupama Reddy, Manway Liu, Lauren Murray, Michael F. Berger, John E. Monahan, Paula Morais, Jodi Meltzer, Adam Korejwa, Judit Jané‐Valbuena, Felipa Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H. Engels, Jill Cheng, Guoying Karen Yu, Jianjun Yu, Peter Aspesi, Melanie de Silva, Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway

Nature. 20128,591 Citations

How much of the research on Spark Therapeutics (United States) is open access?

ScholarIQopen access share

0%OPEN ACCESS

Gold

Green

Hybrid

Bronze

Closed

100%